相关实验视频

Updated: Jul 28, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

与抗Mi-2抗体阳性肺癌相关的多聚质炎

Masafumi Shimoda¹, Yoshiaki Tanaka¹, Atsuo Taniguchi²

¹Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, 3-1-24 Mastuyama, Kiyose, Tokyo 204-8522 Japan.

International cancer conference journal

|May 30, 2023

概括

一个罕见的肺癌相关的多质神炎 (PM) 病例在一名75岁的老人身上被诊断出. 阳性抗Mi-2抗体和增加的肌激酶 (CK) 在化疗中得到改善,这表明癌症和PM之间存在联系.

科学领域:

神经学神经学
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

肺癌可能伴有副瘤综合征,包括肌肉炎.
聚髓炎 (PM) 是一种异常性炎症性肌肉病,其特征是近端肌肉疲弱.
反Mi-2抗体通常与皮肤肌炎有关,而不是PM或癌症.

研究的目的:

报告一种罕见的肺癌相关的多质神炎 (PM) 病例,该病例具有阳性抗Mi-2抗体.
突出癌症患者肌肉炎的诊断考虑因素.
为了证明癌症治疗和PM缓解之间的潜在治疗联系.

主要方法:

一个75岁的男性患有肺癌的病例报告.
临床评估包括近位软弱和肌痛.
实验室测试:肌激酶 (CK) 的升高.
免疫学测试:抗Mi-2抗体呈阳性.
肌肉成像:T2加权/脂肪抑制MRI显示高强度.
治疗方法:为肺癌提供化疗.

主要成果:

患者呈现出近端虚弱和肌痛,CK水平升高,以及阳性抗Mi-2抗体测试.
肌肉MRI显示高信号强度,与肌肉炎一致,在没有皮肤病变的情况下.
确立了肺癌相关的多质神炎 (PM) 的诊断.
在肺癌化疗后,患者在PM症状中逐渐改善,CK水平正常化.

结论:

这一案例表明,抗Mi-2抗体,虽然很少见,但在肺癌的背景下,可以与多质神炎有关.
癌症患者中CK水平升高需要对肌肉炎进行调查,包括对肌肉炎特异性自身抗体的测试.
成功的癌症治疗可能会导致相关的多质神炎的缓解.

关键词:

抗米-2 抗体的抗体与癌症相关的肌肉炎肌氨酸激酶酶的作用是什么肺癌是一种肺癌.聚合神经炎是一种多元神经炎.

更多相关视频

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

Author Spotlight: Enhancing Multicolor Fluorescence Localization in Lung Carcinoma Sample

Author Spotlight: Enhancing Multicolor Fluorescence Localization in Lung Carcinoma Sample

Published on: November 21, 2023

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...